Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 262.91
+5.15 (2.00%)
Jul 31, 2026, 3:15 PM IST
Bafna Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 20.25 | 34.33 | 13.96 | 78.09 | 1.73 |
Cash & Short-Term Investments | 20.25 | 34.33 | 13.96 | 78.09 | 1.73 |
Cash Growth | -41.02% | 145.90% | -82.12% | 4414.10% | -90.41% |
Accounts Receivable | 439.29 | 401.74 | 453.95 | 411.49 | 147.8 |
Receivables | 440.07 | 401.97 | 454.77 | 412.03 | 148.76 |
Inventory | 289.03 | 280.86 | 296.42 | 222.2 | 202.81 |
Prepaid Expenses | - | 5.21 | 4.61 | 3.73 | - |
Other Current Assets | 147.18 | 139.43 | 167.95 | 157.07 | 155.5 |
Total Current Assets | 896.52 | 861.79 | 937.71 | 873.12 | 508.8 |
Property, Plant & Equipment | 849.24 | 660.93 | 507.07 | 402.3 | 388.46 |
Long-Term Investments | 0.01 | 0.01 | - | - | - |
Other Intangible Assets | - | - | 17.7 | 15 | - |
Other Long-Term Assets | 9.56 | 8.07 | 14.34 | 5.42 | 4.19 |
Total Assets | 1,755 | 1,531 | 1,477 | 1,296 | 901.45 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 312.86 | 309.45 | 354.22 | 284.61 | 124.05 |
Accrued Expenses | 14.84 | 32.22 | 30.19 | 27.38 | 33.39 |
Short-Term Debt | - | 85.7 | 100.11 | 119.09 | 45.92 |
Current Portion of Long-Term Debt | 196.51 | 56 | 36.25 | 25.81 | 11.51 |
Current Income Taxes Payable | - | - | - | 0.81 | 0.9 |
Current Unearned Revenue | 3.26 | 1.66 | 0.99 | 0.99 | 0.66 |
Other Current Liabilities | 44.42 | 33.49 | 19.07 | 6.07 | 3.71 |
Total Current Liabilities | 571.9 | 518.52 | 540.83 | 464.76 | 220.13 |
Long-Term Debt | 177.82 | 140.29 | 107.53 | 84.33 | 53.17 |
Long-Term Unearned Revenue | 39.95 | 19.14 | 16.15 | 12.19 | 8.51 |
Other Long-Term Liabilities | 4.16 | 4.78 | 3.92 | - | - |
Total Liabilities | 793.83 | 682.73 | 668.43 | 561.29 | 281.81 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 236.56 | 236.56 | 236.56 | 236.56 | 236.56 |
Additional Paid-In Capital | - | 753.77 | 753.77 | 753.77 | 753.77 |
Retained Earnings | - | -412.08 | -451.75 | -525.6 | -640.51 |
Comprehensive Income & Other | 724.93 | 269.81 | 269.81 | 269.81 | 269.81 |
Total Common Equity | 961.5 | 848.07 | 808.39 | 734.55 | 619.64 |
Shareholders' Equity | 961.5 | 848.07 | 808.39 | 734.55 | 619.64 |
Total Liabilities & Equity | 1,755 | 1,531 | 1,477 | 1,296 | 901.45 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 374.33 | 281.99 | 243.89 | 229.24 | 110.59 |
Net Cash (Debt) | -354.09 | -247.66 | -229.93 | -151.15 | -108.86 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -14.96 | -10.47 | -9.72 | -6.39 | -4.60 |
Filing Date Shares Outstanding | 23.7 | 23.66 | 23.66 | 23.66 | 23.66 |
Total Common Shares Outstanding | 23.7 | 23.66 | 23.66 | 23.66 | 23.66 |
Working Capital | 324.63 | 343.27 | 396.88 | 408.35 | 288.67 |
Book Value Per Share | 40.57 | 35.85 | 34.17 | 31.05 | 26.19 |
Tangible Book Value | 961.5 | 848.07 | 790.69 | 719.55 | 619.64 |
Tangible Book Value Per Share | 40.57 | 35.85 | 33.42 | 30.42 | 26.19 |
Land | - | 1.93 | 1.93 | 1.93 | 1.93 |
Buildings | - | 275.1 | 251.51 | 250.78 | 245.71 |
Machinery | - | 778.25 | 741.42 | 693.86 | 631.75 |
Construction In Progress | - | 73.13 | 104.96 | - | - |